RxDoctor Payments Data

Mona Brownfield, MD

Family Medicine · Boonville, MONPI 1023055605

Payments from drug & device makers

$804in general payments, 2019–2025

Across 62 payments — averaging $12.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$143
  • Johnson & Johnson$132
  • Amgen$99
  • AstraZeneca$78
  • E.r. Squibb & Sons, L.L.C.$56
  • Sunovion Pharmaceuticals Inc.$41
  • plus $254 from 10 others

What the payments were for

  • Food & beverage$79899%
  • Education$51%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$804 in reported general payments places this provider in the 60th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$77,278
Medicare patients
347
Services billed
1,140

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide129$147,092
EliquisApixaban193$114,634
MounjaroTirzepatide70$91,017
XareltoRivaroxaban58$51,335
JanuviaSitagliptin Phosphate44$46,205
FarxigaDapagliflozin Propanediol61$40,822
TrulicityDulaglutide28$36,229
JardianceEmpagliflozin21$27,947
LinzessLinaclotide26$20,520
Trelegy ElliptaFluticasone/Umeclidin/Vilanter32$20,181
MyrbetriqMirabegron30$19,682
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog12$14,319
AbrysvoRsv Vacc, Pref A And Pref B/Pf53$13,641
RybelsusSemaglutide12$13,172
BelbucaBuprenorphine Hcl12$10,479

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$29$160,264141 claims
PfizerEliquis, Abrysvo$143$128,275246 claims
Lilly USA, LLCMounjaro, Trulicity$12$127,24698 claims
Johnson & JohnsonXarelto$132$51,33558 claims
MerckJanuvia$25$46,20544 claims
AstraZenecaFarxiga$78$40,82261 claims
Boehringer IngelheimJardiance, Synjardy$11$35,15933 claims
AbbVieLinzess$32$20,52026 claims
Astellas Pharma US IncMyrbetriq$36$19,68230 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Boonville

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →